Sign in
CompletedNo phase

Efficacy and Safety of the Self-expanding Intracranial Stent (Tonbridge) for Endovascular Treatment of Intracranial Aneurysms

Key facts

Who runs it
Ton-Bridge Medical Tech. Co., Ltd
Where
China14 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
204 people enrolled
Started
14 Feb 2023
Ended
13 Dec 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Self-expanding Intracranial Stent (Tonbridge)
  • LVIS and LVIS Jr. (MicroVention)
Record updated
2 January 2026

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Age 18 to 80 years, any gender
  • Diagnosed as intracranial aneurysm and the subject is assessed as suitable for stent-assisted coiling
  • Subject or guardian is able to understand the purpose of study, shows sufficient compliance with the study protocol and provides a signed informed consent form

Who cannot take part

  • Aneurysm rupture within 30 days before enrollment
  • Heart, lung, liver and renal failure or other severe diseases (intracranial tumor, systemic infection, disseminated intravascular coagulation, myocardial infarction within 12 months before enrollment, history of severe psychosis, severe stenosis or occlusion of cerebral feeding artery, etc.)
  • Major surgery within 30 days before enrollment;
  • Known coagulation dysfunction or contraindication to anticoagulant and antiplatelet therapy
  • Subject has participated in other drug or medical device clinical trials within 1 month before signing informed consent
  • Diagnosed as blood blister-like aneurysm, pseudoaneurysm, infected aneurysm, or aneurysm related to arteriovenous malformations
  • Conditions that are not appropriate for stent delivery and deployment judged by investigators (severe stenosis of parent artery, severe tortuosity of parent artery, stent failing to reach the lesion, stent in the target lesion of parent artery, etc.)
  • Known allergy to nickel-titanium alloy metal materials
  • Other conditions judged by the investigators as unsuitable for enrollment
  • Modified Rankin Scale (mRS) score ≥3
  • Life expectancy <12 months
  • Pregnant or breastfeeding women

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this study is to assess the efficacy and safety of Self-expanding Intracranial Stent (Tonbridge), by comparing the data obtained from Self-expanding Intracranial Stent (Zhuhai Tonbridge Medical Tech. Co., Ltd.) and LVIS/LVIS Jr. (MicroVention Europe SARL) for endovascular treatment of intracranial aneurysms.

The 2 groups in the trial

  • experimental groupTreatment being tested

    Self-expanding Intracranial Stent (Tonbridge)

    Treatment: Self-expanding Intracranial Stent (Tonbridge)

  • control groupExisting treatment, for comparison

    LVIS and LVIS Jr. (MicroVention)

    Treatment: LVIS and LVIS Jr. (MicroVention)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Efficacy and Safety of the Self-expanding Intracranial Stent (Tonbridge) for Endovascular Treatment of Intracranial Aneurysms: A Prospective, Multi-center, Randomized, Open, Parallel Positive Controlled, Non-inferiority Trial
Record updated
2 January 2026